Lipella Pharmaceuticals Eulerpool News

Lipella Pharmaceuticals Notizie Azioni

Lipella Pharmaceuticals è seguito da molti giornalisti e investitori in tutto il mondo. Qui raccogliamo le più recenti notizie Lipella Pharmaceuticals.

• 3 dicembre ·

  Yahoo
  Lipella Pharmaceuticals Announces Publication in CUREUS on Non-Steroid Treatment of Oral Lichen Planus
• 21 novembre ·

  Yahoo
  Lipella Pharmaceuticals Announces Completion of First Cohort in Phase 2a Trial of LP-310 for Oral Lichen Planus, Advancing to Next Dose Group
• 17 novembre ·

  Yahoo
  Lipella Pharmaceuticals Third Quarter 2024 Earnings: US$1.29 loss per share (vs US$1.84 loss in 3Q 2023)
• 12 novembre ·

  Yahoo
  Lipella Pharmaceuticals Secures Extended Market Exclusivity with Issuance of U.S. Patent for Liposomal Delivery Platform
• 3 novembre ·

  Seeking Alpha
  Warning: LIPO is at high risk of performing badly
• 2 novembre ·

  Seeking Alpha
  Warning: LIPO is at high risk of performing badly
• 31 ottobre ·

  Seeking Alpha
  Warning: LIPO is at high risk of performing badly
• 30 ottobre ·

  Seeking Alpha
  Warning: LIPO is at high risk of performing badly
• 29 ottobre ·

  Yahoo
  Lipella Pharmaceuticals to Present at 2024 Spartan Capital Investor Conference
• 28 ottobre ·

  Seeking Alpha
  Warning: LIPO is at high risk of performing badly